The eye is where thymosin beta-4 has the most human data. A plain-language look at the dry eye trials, the p=0.0656 Phase III, and what is still missing.
The published thymosin beta-4 study figures, the animal numbers, and the honest answer for TB-500 itself: no human dose has ever been published.
What a TB-500 certificate of analysis should show, which identity numbers it must match, and why a 2023 peer-reviewed paper says batch testing matters.
One published animal study gave TB-500 itself and measured brain outcomes. Here is what it reported, the result it did not find, and what is still missing.
What amounts has BPC-157 research actually used? The published animal figures, the human-tissue concentrations, and the honest answer on human dosing: none is published.
BPC-157 is studied in animal, cell, and tissue models of tendon, gut, blood vessel, nerve, and wound repair. A plain-language map of every research area.
A plain-language review of published BPC-157 wound research: a burn model, fistula repair in rats, and growth-factor comparisons. Animal and lab data only.
BPC-157 is on the WADA Prohibited List in Section S2, prohibited at all times for tested athletes. What that means, and why the source is no defense.
BPC-157 and KPV are studied for different things, and both appear in gut research. A plain-language look at what the published work covers and what it does not.
A plain-language comparison of BPC-157 and GHK-Cu: structure, size, the pathways each is studied through, the research areas each belongs to, and what neither has been tested for in people.